EMERYVILLE, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will webcast a teleconference with management to provide a general business update on Monday, October 12, 2009, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time).
Interested parties may access a live webcast of the presentation on the company's website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar
or by dialing 847-413-3362 and using the passcode 25577870#. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 25577870# approximately one hour after the teleconference concludes. The replay will be available through November 12, 2009.
About Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com/.
Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.
Onyx Pharmaceuticals, Inc.
CONTACT: Alex Santos for Onyx Pharmaceuticals, +1-510-597-6504
Web Site: http://www.onyx-pharm.com/
